Clinical trial
Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
NCT00188188 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00188188 |
|---|---|
| Title | Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease |
| Official title | Endothelial Dysfunction in Systemic Lupus Erythematosus: Its Contribution to Abnormalities in Coronary Perfusion. |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Heart and Stroke Foundation of Canada |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | quinipril |
| Enrollment | 50 |
| Start date | Mar 1, 2002 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 29, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: